AKBA
Akebia Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.97
−0.87%0
Insider buys (3m)
1
Insider sells (3m)
-$62.2K
Net value (3m)
+5.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 10, 2026 | Butler John P. · director, officer: CEO and President | M-Exempt | 350,000 | $0.63 |
| Jul 1, 2026 | Ostrowski Erik · officer: SVP, CFO, CBO & Treasurer | Sale | 56,019 | $1.11 |
| Jun 22, 2026 | ROGERS MICHAEL W · director | A-Award | 35,700 | $0.00 |
| Jun 22, 2026 | FRIESON RON · director | A-Award | 35,700 | $0.00 |
| Jun 22, 2026 | Wolf Myles · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | ZUMWALT LEANNE M · director | A-Award | 35,700 | $0.00 |
| Jun 22, 2026 | ZUMWALT LEANNE M · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | ADAMS ADRIAN · director | A-Award | 35,700 | $0.00 |
| Jun 22, 2026 | Smith Cynthia · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | ROGERS MICHAEL W · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | ADAMS ADRIAN · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | FRIESON RON · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | Wolf Myles · director | A-Award | 35,700 | $0.00 |
| Jun 22, 2026 | Smith Cynthia · director | A-Award | 35,700 | $0.00 |
| Apr 3, 2026 | Vickers Philip J. · director | A-Award | 214,400 | $1.41 |
| Mar 5, 2026 | Butler John P. · director, officer: CEO and President | Purchase | 69,270 | $1.25 |
| Feb 4, 2026 | Butler John P. · director, officer: CEO and President | Sale | 96,065 | $1.39 |
| Feb 4, 2026 | Burke Steven Keith · officer: SVP, Chief Medical Officer | Sale | 25,375 | $1.39 |
| Feb 4, 2026 | Butler John P. · director, officer: CEO and President | A-Award | 175,250 | $1.41 |
| Feb 4, 2026 | Butler John P. · director, officer: CEO and President | Sale | 46,660 | $1.39 |
| Feb 4, 2026 | Burke Steven Keith · officer: SVP, Chief Medical Officer | Sale | 21,582 | $1.39 |
| Feb 4, 2026 | Malabre Richard C · officer: SVP, Chief Accounting Officer | Sale | 13,382 | $1.39 |
| Feb 4, 2026 | Grund Nicholas · officer: Chief Commercial Officer | Sale | 53,585 | $1.39 |
| Feb 4, 2026 | Rucci Carolyn M. · officer: SVP, Chief Legal Officer | Sale | 27,544 | $1.39 |
| Feb 4, 2026 | Grund Nicholas · officer: Chief Commercial Officer | Sale | 31,244 | $1.39 |
| Feb 4, 2026 | Rucci Carolyn M. · officer: SVP, Chief Legal Officer | Sale | 25,382 | $1.39 |
| Feb 4, 2026 | Malabre Richard C · officer: SVP, Chief Accounting Officer | Sale | 36,142 | $1.39 |
| Feb 4, 2026 | Ostrowski Erik · officer: SVP, CFO, CBO & Treasurer | Sale | 34,951 | $1.39 |
| Feb 4, 2026 | Rucci Carolyn M. · officer: SVP, Chief Legal Officer | Sale | 16,846 | $1.39 |
| Feb 4, 2026 | Butler John P. · director, officer: CEO and President | Sale | 114,891 | $1.39 |
Institutional positioning
13F filings over the trailing two quarters
New 36Increased 43Reduced 57Sold out 169
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 18,693,296 | May 13, 2026 |
| STATE STREET CORP | Reduced | 11,614,006 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 11,166,710 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 6,452,252 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 4,706,437 | Mar 25, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 3,602,827 | May 15, 2026 |
| CITIGROUP INC | Increased | 2,854,586 | May 11, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 2,763,362 | May 18, 2026 |
| QUBE RESEARCH & TECHNOLOGIES LTD | Reduced | 2,395,215 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 2,384,713 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 2,215,441 | May 8, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Reduced | 2,015,577 | May 15, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | Unchanged | 2,000,000 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,981,859 | Sep 2, 2026 |
| NORTHERN TRUST CORP | Reduced | 1,945,586 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 10, 2026